SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-034679
Filing Date
2022-02-10
Accepted
2022-02-10 17:21:52
Documents
2
Group Members
BALDERTON CAPITAL GENERAL PARTNER VI, S.A.R.L.

Document Format Files

Seq Description Document Type Size
1 SC 13G d281631dsc13g.htm SC 13G 56028
2 EXHIBIT 1 d281631dex991.htm EX-99.1 3888
  Complete submission text file 0001193125-22-034679.txt   61471
Mailing Address 2-8 AVENUE CHARLES DE GAULLE LUXEMBOURG N4 L-1653
Business Address 2-8 AVENUE CHARLES DE GAULLE LUXEMBOURG N4 L-1653 352 24 870 210
Balderton Capital VI, S.L.P. (Filed by) CIK: 0001702178 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address RUE DU CENTRE 172, CH-1025 SAINT-SULPICE V8 00000
Business Address RUE DU CENTRE 172, CH-1025 SAINT-SULPICE V8 00000 41 21 694 10 60
SOPHiA GENETICS SA (Subject) CIK: 0001840706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93219 | Film No.: 22615377
SIC: 2836 Biological Products, (No Diagnostic Substances)